Multiplex Assay Kit for Plexin B1 (PLXNB1) ,etc. by FLIA (Flow Luminescence Immunoassay)

PLXN5; SEP; Semaphorin receptor SEP

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Plexin B1 (PLXNB1) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Plexin B1 (PLXNB1) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Plexin B1 (PLXNB1) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Plexin B1 (PLXNB1) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 96-104 101
EDTA plasma(n=5) 97-105 102
heparin plasma(n=5) 80-99 85
sodium citrate plasma(n=5) 92-101 96

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Plexin B1 (PLXNB1) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Plexin B1 (PLXNB1) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Plexin B1 (PLXNB1) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 88-98% 78-89% 84-91% 88-99%
EDTA plasma(n=5) 81-91% 83-91% 97-104% 92-104%
heparin plasma(n=5) 81-95% 86-95% 83-102% 85-93%
sodium citrate plasma(n=5) 87-101% 99-105% 84-91% 84-98%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:PLXNB1) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Expert Opin Ther Targets. Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment Pubmed:25395071
Clinical Lymphoma, Myeloma & Leukemia A Revised Staging System for Waldenström's Macroglobulinemia 10.1016/j.clml.2017.07.146
Clinical Lymphoma, Myeloma & Leukemia Extramedullary Multiple Myeloma: Clinical Features and Prognosis in Argentina 10.1016/j.clml.2017.07.144
Blood Cancer Journal Semaphorin 4D correlates with increased bone resorption, hypercalcemia, and disease stage in newly diagnosed patients with multiple myeloma Pubmed:29748532
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPH358Hu04 Recombinant Plexin B1 (PLXNB1) Positive Control; Immunogen; SDS-PAGE; WB.
RPH358Hu03 Recombinant Plexin B1 (PLXNB1) Positive Control; Immunogen; SDS-PAGE; WB.
RPH358Hu02 Recombinant Plexin B1 (PLXNB1) Positive Control; Immunogen; SDS-PAGE; WB.
RPH358Hu01 Recombinant Plexin B1 (PLXNB1) Positive Control; Immunogen; SDS-PAGE; WB.
PAH358Hu01 Polyclonal Antibody to Plexin B1 (PLXNB1) WB
PAH358Hu03 Polyclonal Antibody to Plexin B1 (PLXNB1) WB; IHC; ICC; IP.
PAH358Hu02 Polyclonal Antibody to Plexin B1 (PLXNB1) WB; IHC; ICC; IP.
SEH358Hu ELISA Kit for Plexin B1 (PLXNB1) Enzyme-linked immunosorbent assay for Antigen Detection.
LMH358Hu Multiplex Assay Kit for Plexin B1 (PLXNB1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.